Isoniazid plasma concentrations in a cohort of South African children with tuberculosis: Implications for international pediatric dosing guidelines

Clinical Infectious Diseases

Volumn 48, Issue 11, 2009, Pages 1547-1553

  Mcllleron, Helen ^a,g   Willemse, Marianne ^d,e   Werely, Cedric J ^e,f   Hussey, Gregory D ^b,c   Schaaf, H Simon ^d,e   Smith, Peter J ^a   Donald, Peter R ^d,e  

^a Division of Clinical Pharmacology   (South Africa)

^b Institute of Infectious Disease and Molecular Medicine   (South Africa)

^c UNIVERSITY OF CAPE TOWN   (South Africa)

^d STELLENBOSCH UNIVERSITY   (South Africa)

^e STELLENBOSCH UNIVERSITY   (South Africa)

^f UNIVERSITY OF STELLENBOSCH   (South Africa)

^g UNIVERSITY OF CAPE TOWN   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

ETHAMBUTOL; ETHIONAMIDE; ISONIAZID; RIFAMPICIN; TUBERCULOSTATIC AGENT;

ACETYLATOR PHENOTYPE; ADOLESCENT; ARTICLE; BODY WEIGHT; CHILD; CLINICAL ASSESSMENT; COHORT ANALYSIS; DOSE RESPONSE; DRUG ABSORPTION; DRUG BLOOD LEVEL; EVALUATION; GENOTYPE; GROUPS BY AGE; HOSPITAL PATIENT; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFANT; KWASHIORKOR; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; PRACTICE GUIDELINE; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; SOUTH AFRICA; TREATMENT DURATION; CHEMISTRY; FEMALE; MALE; PLASMA; TUBERCULOSIS;

ANTITUBERCULAR AGENTS; CHILD, PRESCHOOL; FEMALE; HUMANS; INFANT; ISONIAZID; MALE; PLASMA; SOUTH AFRICA; TUBERCULOSIS;

EID: 66949132162     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/598192     Document Type: Article

References (27)

1. Mitchison DA. Role of individual drugs in the chemotherapy of tuberculosis. Int J Tuberc Lung Dis 2000; 4:796-806.
2. Parkin DP, Vandenplas S, Botha FJH, et al. Trimodality of isoniazid elimination. Am J Respir Crit Care Med 1997; 155:1717-22.
3. Schaaf HS, Parkin DP, Seifart HI, et al. Isoniazid pharmacokinetics in children treated for respiratory tuberculosis. Arch Dis Child 2005; 90: 614-8.
4. Roy V, Tekur U, Chopra K. Pharmacokinetics of isoniazid in pulmonary tuberculosis-a comparative study at two dose levels. Indian Pediatr 1996;33:287-91.
5. Lupasco I, Algeorge G, Ghiu-Cimpeanu V. Taux d'isoniazide actif dans le serum des enfants tuberculeux. Poumon Coeur 1965;21:1105-14.
6. Advenier C, Saint-Aubin A, Scheinmann P, Paupe J. Pharmacocinetique de l'isoniazide chez l'enfant. Rev Fr Mal Respir 1981; 9:365-74.
7. Bouveret JP, Hanoteau J, Gerbeaux J, Houin G, Tillement JP. Variations de l'indice d'inactivation de l'isoniazide au cours des traitements an- tituberculeaux chez l'enfant. Arch Fr Pediatr 1983;40:615-9.
8. Donald PR, Sirgel FA, Botha FJH, et al. The early bactericidal activity of isoniazid related to its dose size in pulmonary tuberculosis. Am J Respir Crit Care Med 1997; 156:895-900.
9. Donald PR, Sirgel FA, Venter A, et al. The influence of human N- acetyltransferase genotype on the early bactericidal activityofisoniazid. Clin Infect Dis 2004;39:1425-30.
10. Tuberculosis Chemotherapy Centre, Madras. A concurrent comparison of isoniazid plus PAS with three regimens of isoniazid alone in the domiciliary treatment of pulmonary tuberculosis in South India. Bull World Health Organ 1960; 23:535-85.
11. Fox W, Ellard GA, Mitchison DA. Studies on the treatment of tuberculosis undertaken by the British Medical Research Council tuberculosis units, 1946-1986, with relevant subsequent publications. Int J Tuberc Lung Dis 1999; 3:S231-79.
12. Peloquin CA. Therapeutic drug monitoring in the treatment of tuberculosis. Drugs 2002;62:2169-83.
13. Weiner M, Burman W, Vernon A, et al. Low isoniazid concentrations and outcome of tuberculosis treatment with once-weekly isoniazid and rifapentine. Am J Respir Crit Care Med 2003; 167:1341-7.
14. Wallis RS, Weyer K, Fourie PB. Acquired rifamycin resistance: pharmacology and biology. Expert Rev Anti Infect Ther 2008; 6:223-30.
15. Donald PR. The assessment of new anti-tuberculosis drugs for a pae- diatric indication. Int J Tuberc Lung Dis 2007; 11:1162-5.
16. Burman WJ, Cotton MF, Gibb DM, Walker AS, Vernon AA, Donald PR. Ensuring the involvement of children in the evaluation of new tuberculosis treatment regimens. PloS Med 2008; 5:e176.
17. World Health Organization. Guidance for national tuberculosis programmes on the management of tuberculosis in children. Document WHO/HTM/TB/2006.371. Geneva: World Health Organization, 2006. Available at: http://www.who.int/tb/publications/2006/en/index.html. Accessed 24 October 2008.
18. Tuberculosis Coalition for Technical Assistance. International standards for tuberculosis care. The Hague: Tuberculosis Coalition for Technical Assistance, 2006. Available at: http://www.tbcta.org/TB-CAP-Toolbox/ #15. Accessed 24 October 2008.
19. National Tuberculosis Control Programme practical guidelines 2000. Pretoria, South Africa: Department of Health, Republic of South Africa, 2000. Available at: http://www.doh.gov.za/tb/index.html (under Resources: Basic documents and reports). Accessed 24 October 2008.
20. Guidelines for good practice in the conduct of clinical trials in human participants in South Africa. Pretoria, South Africa: Department of Health, Republic of South Africa, 2000. Available at: http://www.doh .gov.za/docs/policy/trials/trials-full.html. Accessed 24 October 2008.
21. Mcllleron H, Wash P, Burger A, Norman J, Folb PI, Smith P. Determinants of rifampin, isoniazid, pyrazinamide, and ethambutol phar- macokinetics in a cohort of tuberculosis patients. Antimicrob Agents Chemother 2006;50:1170-7.
22. Rimactazid Paed 60/60 tablets (rifampicin and isoniazid) [package insert]. Kempton Park, South Africa: Rolab, 1998.
23. Rimactazid Paed 60/30 tablets (rifampicin and isoniazid) [package insert]. Kempton Park, South Africa: Rolab, 1998.
24. Rimcure Paed 3-FDC tablets (rifampicin, isoniazid, and pyrazinamide) [package insert]. Kempton Park, South Africa: Rolab, 1998.
25. Wu SS, Chao CS, Vargas JH, et al. Isoniazid-related hepatic failure in children: a survey of liver transplantation centers. Transplantation 2007;84:173-9.
26. Morales SM, Lincoln EM. The effect ofisoniazid therapyon pyridoxine metabolism in children. Am Rev Tuberc 1957;75:594-600.
27. Miller FJW, Seal RME, Taylor MD. Tuberculosis in children. London: J & A Churchill, 1963:163-87.